Nasdaq · Common stock
TRex Bio (TRXB)
$13.87 +$0.06 (+0.43%)
- Day’s range
- $13.56–$14.64
- Volume
- 54,975
TRXB price history
TRXB closed at $13.87 on Oct. 26, 2026. Over the past year, its daily close ranged from $13.50 on Oct. 14, 2026 to $15.50 on Oct. 22, 2026.
Data table: TRXB daily closes, the past year
| Date | Close |
|---|---|
| Oct. 26, 2026 | $13.87 |
| Oct. 23, 2026 | $13.81 |
| Oct. 22, 2026 | $15.50 |
| Oct. 21, 2026 | $15.24 |
| Oct. 20, 2026 | $14.44 |
| Oct. 19, 2026 | $14.80 |
| Oct. 16, 2026 | $14.01 |
| Oct. 15, 2026 | $14.16 |
| Oct. 14, 2026 | $13.50 |
| Oct. 13, 2026 | $13.60 |
| Oct. 12, 2026 | $14.03 |
| Oct. 9, 2026 | $14.00 |
Key figures
- Average daily volume
- 217,860Past 3 months
- Market value
- $380.7M
- Dividend yield
- —
What Wall Street says about TRXB
No Wall Street firm has published a rating or price-target change on TRXB in the past 90 days.
Ratings and price targets are the firms’ own opinions, reported as published.
Not investment advice.
About TRex Bio, Inc. Common stock
Trex Bio Inc is a clinical-stage biopharmaceutical company focused on tissue Treg biology for the discovery and development of immunoregulatory medicines designed to restore immune balance and promote tissue repair to address unmet needs of patients with autoimmune and inflammatory diseases.
- Listed
- Oct. 9, 2026
In WallStreetDigest editions
No WallStreetDigest article about TRXB is on the site yet.